Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation - PubMed (original) (raw)
Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation
Y Tsujimoto et al. Science. 1984.
Abstract
From an acute B-cell leukemia cell line, a DNA probe was obtained that was specific for chromosome 18 and flanked the heavy chain joining region of the immunoglobulin heavy chain locus on chromosome 14. This probe detected rearrangement of the homologous DNA segment in the leukemic cells and in follicular lymphoma cells with the t(14:18) chromosome translocation but not in other neoplastic or normal B or T cells. The probe appears to identify bcl-2, a gene locus on chromosome 18 (band q21) that is unrelated to known oncogenes and may be important in the pathogenesis of B-cell neoplasms with this translocation.
Similar articles
- Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation.
Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM. Tsujimoto Y, et al. Science. 1984 Jun 29;224(4656):1403-6. doi: 10.1126/science.6610211. Science. 1984. PMID: 6610211 - Pre-B-cell leukemia with a t(8; 14) and a t(14; 18) translocation is preceded by follicular lymphoma.
Gauwerky CE, Hoxie J, Nowell PC, Croce CM. Gauwerky CE, et al. Oncogene. 1988 May;2(5):431-5. Oncogene. 1988. PMID: 3131717 - The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus.
Erikson J, Finan J, Tsujimoto Y, Nowell PC, Croce CM. Erikson J, et al. Proc Natl Acad Sci U S A. 1984 Jul;81(13):4144-8. doi: 10.1073/pnas.81.13.4144. Proc Natl Acad Sci U S A. 1984. PMID: 6429662 Free PMC article. - The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F, Pisegna S, Diverio D. Lo Coco F, et al. Haematologica. 1997 May-Jun;82(3):364-70. Haematologica. 1997. PMID: 9234595 Review.
Cited by
- Effects of Peptide-Induced Immune Tolerance on Murine Lupus.
Singh RP, Hahn BH, Bischoff DS. Singh RP, et al. Front Immunol. 2021 May 19;12:662901. doi: 10.3389/fimmu.2021.662901. eCollection 2021. Front Immunol. 2021. PMID: 34093553 Free PMC article. - Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer.
Fairlie WD, Lee EF. Fairlie WD, et al. Int J Mol Sci. 2021 Mar 11;22(6):2841. doi: 10.3390/ijms22062841. Int J Mol Sci. 2021. PMID: 33799592 Free PMC article. Review. - VDAC1: from structure to cancer therapy.
Shoshan-Barmatz V, Mizrachi D. Shoshan-Barmatz V, et al. Front Oncol. 2012 Nov 29;2:164. doi: 10.3389/fonc.2012.00164. eCollection 2012. Front Oncol. 2012. PMID: 23233904 Free PMC article. - Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.
Winfield LL, Payton-Stewart F. Winfield LL, et al. Future Med Chem. 2012 Mar;4(3):361-83. doi: 10.4155/fmc.11.177. Future Med Chem. 2012. PMID: 22393942 Free PMC article. Review. - A competitive stapled peptide screen identifies a selective small molecule that overcomes MCL-1-dependent leukemia cell survival.
Cohen NA, Stewart ML, Gavathiotis E, Tepper JL, Bruekner SR, Koss B, Opferman JT, Walensky LD. Cohen NA, et al. Chem Biol. 2012 Sep 21;19(9):1175-86. doi: 10.1016/j.chembiol.2012.07.018. Chem Biol. 2012. PMID: 22999885 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials